Coherus Biosciences (CHRS) PT Lowered to $27 at Truist Securities

February 26, 2021 7:34 AM EST
Get Alerts CHRS Hot Sheet
Price: $13.95 -1.06%

Rating Summary:
    11 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE
Truist Securities lowered its price target on Coherus Biosciences (NASDAQ: CHRS) to $27.00 (from $30.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change